PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jan-2024 Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan AccessWire
04-Jan-2024 Abivax 2024 Financial Communication Calendar ABIVAX
04-Jan-2024 Angle PLC Announces Breakthrough Clinical Results AccessWire
04-Jan-2024 Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I Evotec SE
04-Jan-2024 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA AccessWire
04-Jan-2024 Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
04-Jan-2024 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA Kuros Biosciences AG
03-Jan-2024 Best Dentists in Baltimore 2023 by TopRatedDentist.com AccessWire
03-Jan-2024 Pioneering initiative launched to increase the number of pharmacists in the South West University of Bath
03-Jan-2024 OncoZenge submits application for PRIME status in the EU OncoZenge
03-Jan-2024 AMLo Biosciences publish pivotal data for diagnostic biomarker technology AMBLor® in identifying melanomas at low risk of metastasis AMLo Biosciences
03-Jan-2024 iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference iTeos Therapeutics, Inc.
03-Jan-2024 PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference PureTech Health plc
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults Mundipharma
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 NICE publishes positive final draft guidance for Sanofi’s innovative medicine Rezurock® (belumosudil) for patients with chronic graft-versus-host disease (cGVHD) that will receive immediate funding through the Innovative Medicines Fund (IMF) Sanofi
03-Jan-2024 Calibre Scientific Acquires LineaLAB Calibre Scientific
03-Jan-2024 Longest strike in NHS history leaves local services ‘skating on the thinnest of ice’, warn NHS leaders NHS Confederation
03-Jan-2024 Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year AccessWire